logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tomoko Kataoka

national cancer center - japan
H指数:19
被引数:1,704

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground- glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial
LANCET RESPIRATORY MEDICINE
IF32.8
2023-06-0189
PRE
Aokage, Keiju; Suzuki, Kenji; Saji, Hisashi; Wakabayashi, Masashi; Kataoka, Tomoko; Sekino, Yuta; Fukuda, Haruhiko; Endo, Makoto; Hattori, Aritoshi; Mimae, Takahiro; Miyoshi, Tomohiro; Isaka, Mitsuhiro; Yoshioka, Hiroshige; Nakajima, Ryu; Nakagawa, Kazuo; Okami, Jiro; Ito, Hiroyuki; Kuroda, Hiroaki; Tsuboi, Masahiro; Okumura, Norihito; Takahama, Makoto; Ohde, Yasuhisa; Aoki, Tadashi; Tsutani, Yasuhiro; Okada, Morihito
Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib

第二步研究方案，日本临床肿瘤学组研究JCOG1802: 晚期软组织肉瘤二线治疗的随机II期试验，比较小梁肽，艾日布林和帕唑帕尼

BMC CANCER
IF3.4
2023-03-081
OAAI
Endo, Makoto; Kataoka, Tomoko; Fujiwara, Toshifumi; Tsukushi, Satoshi; Takahashi, Masanobu; Kobayashi, Eisuke; Yamada, Yoko; Tanaka, Takaaki; Nezu, Yutaka; Hiraga, Hiroaki; Wasa, Junji; Nagano, Akihito; Nakano, Kenji; Nakayama, Robert; Hamada, Tetsuya; Kawano, Masanori; Torigoe, Tomoaki; Sakamoto, Akio; Asanuma, Kunihiro; Morii, Takeshi; Machida, Ryunosuke; Sekino, Yuta; Fukuda, Haruhiko; Oda, Yoshinao; Ozaki, Toshifumi; Tanaka, Kazuhiro
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)

改良FOLFIRINOX与吉西他滨联合nab-紫杉醇治疗局部晚期胰腺癌的随机II期研究 (JCOG1407)

EUROPEAN JOURNAL OF CANCER
IF7.1
2023-03-0135
OAAI
Ozaka, Masato; Nakachi, Kohei; Kobayashi, Satoshi; Ohba, Akihiro; Imaoka, Hiroshi; Terashima, Takeshi; Ishii, Hiroshi; Mizusawa, Junki; Katayama, Hiroshi; Kataoka, Tomoko; Okusaka, Takuji; Ikeda, Masafumi; Sasahira, Naoki; Miwa, Haruo; Mizukoshi, Eishiro; Okano, Naohiro; Mizuno, Nobumasa; Yamamoto, Tomohisa; Komatsu, Yoshito; Todaka, Akiko; Kamata, Ken; Furukawa, Masayuki; Fujimori, Nao; Katanuma, Akio; Takayama, Yukiko; Tsumura, Hidetaka; Fukuda, Haruhiko; Ueno, Makoto; Furuse, Junji
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
LANCET
IF88.5
2023-01-01104
PRE
Nakachi, Kohei; Ikeda, Masafumi; Konishi, Masaru; Nomura, Shogo; Katayama, Hiroshi; Kataoka, Tomoko; Todaka, Akiko; Yanagimoto, Hiroaki; Morinaga, Soichiro; Kobayashi, Shogo; Shimada, Kazuaki; Takahashi, Yu; Nakagohri, Toshio; Gotoh, Kunihito; Kamata, Ken; Shimizu, Yasuhiro; Ueno, Makoto; Ishii, Hiroshi; Okusaka, Takuji; Furuse, Junji
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105
HEMATOLOGICAL ONCOLOGY
IF3.9
2022-11-301
PRE
Suzuki, Tomotaka; Maruyama, Dai; Machida, Ryunosuke; Kataoka, Tomoko; Fukushima, Noriyasu; Takayama, Nobuyuki; Ohba, Rie; Omachi, Ken; Imaizumi, Yoshitaka; Tokunaga, Masahito; Katsuya, Hiroo; Yoshida, Isao; Sunami, Kazutaka; Kurosawa, Mitsutoshi; Kubota, Nobuko; Morimoto, Hiroaki; Kobayashi, Miki; Yamamoto, Kazuhito; Kameoka, Yoshihiro; Kagami, Yoshitoyo; Tabayashi, Takayuki; Maruta, Masaki; Kobayashi, Tsutomu; Iida, Shinsuke; Nagai, Hirokazu
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306
BRITISH JOURNAL OF CANCER
IF6.8
2022-07-2311
OA
Tanaka, Kazuhiro; Machida, Ryunosuke; Kawai, Akira; Nakayama, Robert; Tsukushi, Satoshi; Asanuma, Kunihiro; Matsumoto, Yoshihiro; Hiraga, Hiroaki; Hiraoka, Koji; Watanuki, Munenori; Yonemoto, Tsukasa; Abe, Satoshi; Katagiri, Hirohisa; Nishida, Yoshihiro; Nagano, Akihito; Suehara, Yoshiyuki; Kawashima, Hiroyuki; Kawano, Masanori; Morii, Takeshi; Hatano, Hiroshi; Toguchida, Junya; Okuma, Tomotake; Takeyama, Masanobu; Takenaka, Satoshi; Akisue, Toshihiro; Furuta, Taisuke; Emori, Makoto; Hiruma, Toru; Outani, Hidetatsu; Yamamoto, Tetsuji; Kataoka, Tomoko; Fukuda, Haruhiko; Ozaki, Toshifumi; Iwamoto, Yukihide
A Multicenter, Randomized Phase III Study Comparing Platinum Combination Chemotherapy Plus Pembrolizumab With Platinum Combination Chemotherapy Plus Nivolumab and Ipilimumab for Treatment-Naive Advanced Non-Small Cell Lung Cancer Without Driver Gene Alterations: JCOG2007 (NIPPON Study)
CLINICAL LUNG CANCER
IF3.3
2022-06-0119
OAAI
Shiraishi, Yoshimasa; Hakozaki, Taiki; Nomura, Shogo; Kataoka, Tomoko; Tanaka, Kentaro; Miura, Satoru; Sekino, Yuta; Ando, Masahiko; Horinouchi, Hidehito; Ohe, Yuichiro; Okamoto, Isamu
A randomized controlled phase III study of bevacizumab and paclitaxel in combination with atezolizumab as a treatment for patients with locally advanced or metastatic hormone receptor-positive HER2 negative breast cancer: JCOG1919E/AMBITION study
CANCER RESEARCH
IF16.6
2022-02-151
PRE
Hara, Fumikata; Ono, Makiko; Kitano, Shigehisa; Saji, Shigehira; Shimomura, Akihiko; Yamanaka, Takashi; Kadoya, Takayuki; Ito, Mitsuya; Bando, Hiroko; Yasojima, Hiroyuki; Sasaki, Keita; Kataoka, Tomoko; Shien, Tadahiko; Yonemori, Kan; Iwata, Hiroji
The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113
SCIENTIFIC REPORTS
IF3.9
2022-01-195
OAAI
Yamada, Ikuhiro; Morizane, Chigusa; Okusaka, Takuji; Mizusawa, Junki; Kataoka, Tomoko; Ueno, Makoto; Ikeda, Masafumi; Okano, Naohiro; Todaka, Akiko; Shimizu, Satoshi; Mizuno, Nobumasa; Sekimoto, Mitsugu; Tobimatsu, Kazutoshi; Yamaguchi, Hironori; Nishina, Tomohiro; Shirakawa, Hirofumi; Kojima, Yasushi; Oono, Takamasa; Kawamoto, Yasuyuki; Furukawa, Masayuki; Iwai, Tomohisa; Sudo, Kentaro; Okamura, Keiya; Yamashita, Tatsuya; Kato, Naoya; Shioji, Kazuhiko; Shimizu, Kyouko; Nakagohri, Toshio; Kamata, Ken; Ishii, Hiroshi; Furuse, Junji
Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113
SCIENTIFIC REPORTS
IF3.9
2021-06-183
OAAI
Ueno, Makoto; Morizane, Chigusa; Okusaka, Takuji; Mizusawa, Junki; Kataoka, Tomoko; Ikeda, Masafumi; Ozaka, Masato; Okano, Naohiro; Sugimori, Kazuya; Todaka, Akiko; Shimizu, Satoshi; Mizuno, Nobumasa; Yamamoto, Tomohisa; Sano, Keiji; Tobimatsu, Kazutoshi; Katanuma, Akio; Miyamoto, Atsushi; Yamaguchi, Hironori; Nishina, Tomohiro; Shirakawa, Hirofumi; Kojima, Yasushi; Oono, Takamasa; Kawamoto, Yasuyuki; Furukawa, Masayuki; Iwai, Tomohisa; Sudo, Kentaro; Miyakawa, Hiroyuki; Yamashita, Tatsuya; Yasuda, Ichirou; Takahashi, Hidenori; Kato, Naoya; Shioji, Kazuhiko; Shimizu, Kyoko; Nakagohri, Toshio; Kamata, Ken; Ishii, Hiroshi; Furuse, Junji

研究方向

暂未获取到该数据
J
Junji Furuse
H 指数:75论文数:731被引数:2.8万
M
Masafumi Ikeda
H 指数:76论文数:1,020被引数:3.4万
T
Takayuki Kadoya
H 指数:25论文数:178被引数:2,566
H
Haruhiko Fukuda
H 指数:55论文数:371被引数:1.6万
N
Naohiro Okano
H 指数:20论文数:184被引数:1,989
M
Makoto Ueno
H 指数:45论文数:570被引数:1.0万
H
Hiroshi Ishii
H 指数:48论文数:304被引数:7,404
A
Akiko Todaka
H 指数:22论文数:173被引数:1,572
Y
Yuta Sekino
H 指数:13论文数:78被引数:762
K
Ken Kamata
H 指数:37论文数:289被引数:5,276